Premium
Diagnosis and Treatment of Cervical Carcinomas
Publication year - 2002
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(02)90092-5
Subject(s) - medicine , cervical cancer , radiation therapy , adenocarcinoma , incidence (geometry) , gynecology , cisplatin , cervical carcinoma , oncology , cervix , obstetrics , carcinoma , obstetrics and gynaecology , cancer , chemotherapy , general surgery , pregnancy , physics , biology , optics , genetics
Invasive cervical carcinoma, once the most common reproductive‐tract cancer in the United States, has recently fallen to the rank of third most common. Globally, cervical cancer is a major health problem, with a yearly incidence of 371,000 cases and an annual death of 190,000. The International Federation of Gynecology and Obstetrics (FIGO) recently revisited its staging criteria. In addition, new evidence had documented conclusively that survival rates for women with cervical cancer improve when radiotherapy is combined with cisplatin‐based chemotherapy. This document will describe staging criteria and treatment for cervical carcinoma. For practical purposes, it will focus on the squamous and adenocarcinoma histologies only.